HFA Icon

Credit Suisse Like Pharma On Tax Changes

HFA Padded
Mark Melin
Published on
Updated on
Sign up for our E-mail List and Get FREE Access to Exclusive Investment E-books and More!

In its 2017 Global Equity Strategy report, Credit Suisse at times appears to follow consensus thinking but at times includes recommendations that appear on the edges. It breaches the conversation regarding “fiscal easing funded by the central bank” as it considers the major themes of “Fiscal QE” and targeting “that segment of the workforce who lost out to globalization.” Disruption and China as a competitive threat are themes as the report ponders how investors should play rising bond yields amid potential inflation? It is in this vein the bank is recommending an exposure reduction to the European banking sector and utilities while remaining overweight big cap pharma.

connection lost 3498366 1280

Credit Suisse downplays quantitative monetary...

Login required to continue reading.

Setup a free account to get access to this article (no credit card required).

View Full Article
Already a member? Log in here

HFA Padded

Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.